東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Toxicity testing." ]

切換: 標籤 | MARC模式 | ISBD

A systems biology approach to advanc...

Garcia-Reyero, Natalia.

FindBook

Google Book

Amazon

博客來

A systems biology approach to advancing adverse outcome pathways for risk assessment

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	A systems biology approach to advancing adverse outcome pathways for risk assessment/ edited by Natalia Garcia-Reyero, Cheryl A. Murphy.
其他作者:	Garcia-Reyero, Natalia.
出版者:	Cham :Springer International Publishing : : 2018.,
面頁冊數:	xiv, 422 p. :ill., digital ;24 cm.
內容註:	1. Introduction -- Part I: Biology -- 2. "Non-model" species for eco and human health risk assessment -- 3.The fish embryo as a model for eco-toxicology and other potential models -- 4.Invertebrates/Plants -- 5.Behavioral/Neurobehavioral linkages to AOPs -- 6. Species extrapolation - common pathways etc -- 7. Life History Evolution, incorporating evolutionary processes into AOPs to extrapolate -- Part II: Incorporating Biology into AOPs -- 8.Use of HTS assays to infer MIEs -- 9. AOP development: how to infer and define KER -- 10. The development of quantitative AOPs -- Part IV: Incorporating Modeling into AOPs -- 11.Computational approaches (network science, etc) in AOPs: linking molecular datasets -- 12.Computational approaches : Dynamic Energy Budgets -- 13. Modeling approaches in AOPs: extrapolation from individual to population -- 14. Modeling approaches that augment AOPs: GUTS, QSAR, TKTD PBTKTD -- 15. Exposure science and other stressors? How to incorporate -- 16. AOP as an organizing framework and implications for biological science-AOP evolution -- 17. Use and acceptance of AOPs for regulatory applications, use of AOPs in human risk assessment, and legislation.
Contained By:	Springer eBooks
標題:	Toxicity testing. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-66084-4
ISBN:	9783319660844

A systems biology approach to advancing adverse outcome pathways for risk assessment
A systems biology approach to advancing adverse outcome pathways for risk assessment[electronic resource] /edited by Natalia Garcia-Reyero, Cheryl A. Murphy. - Cham :Springer International Publishing :2018. - xiv, 422 p. :ill., digital ;24 cm.

1. Introduction -- Part I: Biology -- 2. "Non-model" species for eco and human health risk assessment -- 3.The fish embryo as a model for eco-toxicology and other potential models -- 4.Invertebrates/Plants -- 5.Behavioral/Neurobehavioral linkages to AOPs -- 6. Species extrapolation - common pathways etc -- 7. Life History Evolution, incorporating evolutionary processes into AOPs to extrapolate -- Part II: Incorporating Biology into AOPs -- 8.Use of HTS assays to infer MIEs -- 9. AOP development: how to infer and define KER -- 10. The development of quantitative AOPs -- Part IV: Incorporating Modeling into AOPs -- 11.Computational approaches (network science, etc) in AOPs: linking molecular datasets -- 12.Computational approaches : Dynamic Energy Budgets -- 13. Modeling approaches in AOPs: extrapolation from individual to population -- 14. Modeling approaches that augment AOPs: GUTS, QSAR, TKTD PBTKTD -- 15. Exposure science and other stressors? How to incorporate -- 16. AOP as an organizing framework and implications for biological science-AOP evolution -- 17. Use and acceptance of AOPs for regulatory applications, use of AOPs in human risk assessment, and legislation.

Social pressure to minimize the use of animal testing, the ever-increasing concern on animal welfare, and the need for more human-relevant and more predictive toxicity tests are some of the drivers for new approaches to chemical screening. This book focuses on The Adverse Outcome Pathway, an analytical construct that describes a sequential chain of causally linked events at different levels of biological organization that lead to an adverse health or ecotoxicological effect. While past efforts have focused on toxicological pathway-based vision for human and ecological health assessment relying on in vitro systems and predictive models, The Adverse Outcome Pathway framework provides a simplified and structured way to organize toxicological information. Within the book, a systems biology approach supplies the tools to infer, link, and quantify the molecular initiating events and the key events and key event relationships leading to adverse outcomes. The advancement of these tools is crucial for the successful implementation of AOPs for regulatory purposes.

ISBN: 9783319660844

Standard No.: 10.1007/978-3-319-66084-4doiSubjects--Topical Terms:

548609
Toxicity testing.

LC Class. No.: RA1199

Dewey Class. No.: 615.7040724

A systems biology approach to advancing adverse outcome pathways for risk assessment
LDR:03294nmm a2200325 a 4500 001 2133739
003 DE-He213
005 20180821162858.0
006 m d
007 cr nn 008maaau
008 181005s2018 gw s 0 eng d
020 $a 9783319660844 $q (electronic bk.)
020 $a 9783319660820 $q (paper)
024 7 $a 10.1007/978-3-319-66084-4 $2 doi
035 $a 978-3-319-66084-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RA1199
072 7 $a PSA $2 bicssc
072 7 $a SCI086000 $2 bisacsh
072 7 $a SCI064000 $2 bisacsh
082 0 4 $a 615.7040724 $2 23
090 $a RA1199 $b .S995 2018
245 0 2 $a A systems biology approach to advancing adverse outcome pathways for risk assessment $h [electronic resource] / $c edited by Natalia Garcia-Reyero, Cheryl A. Murphy.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xiv, 422 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Introduction -- Part I: Biology -- 2. "Non-model" species for eco and human health risk assessment -- 3.The fish embryo as a model for eco-toxicology and other potential models -- 4.Invertebrates/Plants -- 5.Behavioral/Neurobehavioral linkages to AOPs -- 6. Species extrapolation - common pathways etc -- 7. Life History Evolution, incorporating evolutionary processes into AOPs to extrapolate -- Part II: Incorporating Biology into AOPs -- 8.Use of HTS assays to infer MIEs -- 9. AOP development: how to infer and define KER -- 10. The development of quantitative AOPs -- Part IV: Incorporating Modeling into AOPs -- 11.Computational approaches (network science, etc) in AOPs: linking molecular datasets -- 12.Computational approaches : Dynamic Energy Budgets -- 13. Modeling approaches in AOPs: extrapolation from individual to population -- 14. Modeling approaches that augment AOPs: GUTS, QSAR, TKTD PBTKTD -- 15. Exposure science and other stressors? How to incorporate -- 16. AOP as an organizing framework and implications for biological science-AOP evolution -- 17. Use and acceptance of AOPs for regulatory applications, use of AOPs in human risk assessment, and legislation.
520 $a Social pressure to minimize the use of animal testing, the ever-increasing concern on animal welfare, and the need for more human-relevant and more predictive toxicity tests are some of the drivers for new approaches to chemical screening. This book focuses on The Adverse Outcome Pathway, an analytical construct that describes a sequential chain of causally linked events at different levels of biological organization that lead to an adverse health or ecotoxicological effect. While past efforts have focused on toxicological pathway-based vision for human and ecological health assessment relying on in vitro systems and predictive models, The Adverse Outcome Pathway framework provides a simplified and structured way to organize toxicological information. Within the book, a systems biology approach supplies the tools to infer, link, and quantify the molecular initiating events and the key events and key event relationships leading to adverse outcomes. The advancement of these tools is crucial for the successful implementation of AOPs for regulatory purposes.
650 0 $a Toxicity testing. $3 548609
650 0 $a Systems biology. $3 905904
650 1 4 $a Life Sciences. $3 890838
650 2 4 $a Systems Biology. $3 928020
650 2 4 $a Pharmacology/Toxicology. $3 890953
700 1 $a Garcia-Reyero, Natalia. $3 3301510
700 1 $a Murphy, Cheryl A. $3 3301511
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-66084-4
950 $a Biomedical and Life Sciences (Springer-11642)